Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer

被引:41
作者
Guo, Jing [1 ,2 ]
Chen, Shangxiang [1 ,2 ]
Chen, Yongming [1 ,2 ]
Li, Shun [1 ,2 ]
Xu, Dazhi [1 ,2 ]
机构
[1] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Gastr Surg, Canc Ctr, 651 East Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2018年 / 10卷
关键词
inflammation index; NLR; CRP; combination; prognosis; gastric cancer; REACTIVE PROTEIN/ALBUMIN RATIO; CURATIVE RESECTION; INFLAMMATION; PROTEIN; GASTRECTOMY; LYMPHOCYTE; NEUTROPHIL; PROGNOSIS; INDEX;
D O I
10.2147/CMAR.S156071
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: C-reactive protein (CRP) and neutrophil to lymphocyte ratio (NLR) were independent predictive factors for gastric cancer (GC). Our study was designed to prove the prognostic value of the combination of CRP and NLR (COC-NLR) in GC patients. Materials and methods: A total of 1,058 GC patients who underwent D2 resection from Sun Yat-Sen University Cancer Center between 2003 and 2013 were included. They were divided into three groups (low: NLR <= 2.5, CRP <= 6.1; medium: NLR >2.5, CRP <= 4.5; high: NLR >2.5, CRP >4.5 or NLR <= 2.5, CRP >6.1) by the random forest method. Survival analysis stratified by COC-NLR groups was performed. Results: The mean survival time for each group was: for the low group 75.44 months (95% CI: 72.48-78.40), the medium group 56.50 months (95% CI: 50.68-62.31), and the high group 38.65 months (95% CI: 34.51-42.97). The low group showed obviously better overall survival (OS) than other two groups (p<0.001). Survival analysis showed that COC-NLR had statistical significance in both univariate and multivariate analyses (p<0.01). Conclusion: This study showed that COC-NLR could work as an independent prognostic factor in GC and provide more accurate prediction than single NLR or CRP.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 34 条
  • [1] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [2] Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
    Bang, Yung-Jue
    Kim, Young-Woo
    Yang, Han-Kwang
    Chung, Hyun Cheol
    Park, Young-Kyu
    Lee, Kyung Hee
    Lee, Keun-Wook
    Kim, Yong Ho
    Noh, Sang-Ik
    Cho, Jae Yong
    Mok, Young Jae
    Kim, Yeul Hong
    Ji, Jiafu
    Yeh, Ta-Sen
    Button, Peter
    Sirzen, Florin
    Noh, Sung Hoon
    [J]. LANCET, 2012, 379 (9813) : 315 - 321
  • [3] Systematic review and meta-analysis of enhanced recovery programmes in gastric cancer surgery
    Beamish, Andrew James
    Chan, David Sheng Yi
    Blake, Paul A.
    Karran, Alexandra
    Lewis, Wyn Griffith
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2015, 19 : 46 - 54
  • [4] Random forests
    Breiman, L
    [J]. MACHINE LEARNING, 2001, 45 (01) : 5 - 32
  • [5] Prediction of protein-protein interactions using random decision forest framework
    Chen, XW
    Liu, M
    [J]. BIOINFORMATICS, 2005, 21 (24) : 4394 - 4400
  • [6] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867
  • [7] Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome
    Fairclough, Emily
    Cairns, Eleanor
    Hamilton, Jennifer
    Kelly, Clive
    [J]. CLINICAL MEDICINE, 2009, 9 (01) : 30 - 33
  • [8] Estimation of the Youden index and its associated cutoff point
    Fluss, R
    Faraggi, D
    Reiser, B
    [J]. BIOMETRICAL JOURNAL, 2005, 47 (04) : 458 - 472
  • [9] The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: A literature review
    Gao, Yongyin
    Huang, Dingzhi
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 799 - 804
  • [10] Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
    Hu, Bo
    Yang, Xin-Rong
    Xu, Yang
    Sun, Yun-Fan
    Sun, Chao
    Guo, Wei
    Zhang, Xin
    Wang, Wei-Min
    Qiu, Shuang-Jian
    Zhou, Jian
    Fan, Jia
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (23) : 6212 - 6222